title: Involvement of uterine cervix as the first manifestation of granulomatosis with polyangiitis.
authors.affiliation: Division of Internal Medicine Department of Medicine Centre Hospitalier de l'Université de Montréal Montréal, Québec, Canada Department of Obstetrics and Gynecology Centre Hospitalier de l'Université de Montréal Montréal, Québec, Canada Department of Pathology Centre Hospitalier de l'Université de Montréal Montréal, Québec, Canada Division of Rheumatology Department of Medicine Centre hospitalier de l'Université de Montréal Montréal, Québec, Canada josiane.bourre.tessier@umontreal.ca.
authors.forename: François
authors.initials: F
authors.lastname: Caron
authors.forename: Raymonde
authors.initials: R
authors.lastname: Michaud
authors.forename: Gilles
authors.initials: G
authors.lastname: Gariépy
authors.forename: Josiane
authors.initials: J
authors.lastname: Bourré-Tessier
mesh_terms: D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis; D001707:Biopsy, Needle; D002097:C-Reactive Protein / Q000032:analysis; D003127:Colposcopy / Q000379:methods; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D035583:Rare Diseases; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome; D002577:Uterine Cervical Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D002097:C-Reactive Protein; D011239:Prednisolone; D008727:Methotrexate